Peptides 48 , 3644 (2013)
Guidance for Prescribing Glucagon-like peptide 1 (GLP 1) agonists
In adults, approved indications for growth hormone therapy include childhood-onset growth hormone deficiency, adult-onset hypopituitarism (underactive pituitary gland) due to pituitary or hypothalamic disease, AIDS-related wasting syndrome, and short bowel syndrome (18, 19)
There is always a need for more treatment options due to obesitys health risks, as well as the difficulty many patients experience losing weight and keeping it off
Within the first week, my late-night cravings dropped noticeably
It's important to note that when used as monotherapy, GLP-1 receptor agonists like semaglutide have a low risk of causing hypoglycemia